10x Genomics, Moderna, Novo Nordisk among newly confirmed speakers for Patent Litigation Europe event (pharma & tech) next month

In September, ip fray announced it is the official media partner for Kisaco Research’s annual Pharma and Biotech Patent Litigation Summit Europe, which will be held at the Beurs van Berlage in Amsterdam from January 18 to January 21, 2026 (September 11, 2025 ip fray article). We will report before, during, and after the event, which is expected to host roughly 800 attendees, with 45% in-house counsel, and has been re-branded to include a dedicated track for tech and innovation litigation, too.

The full agenda has now been published and can be found here. It features over 140 IP litigation experts speaking from the judiciary, in-house, and within private practice.

Here is a short program overview:

UPC Litigation Forum – January 19

A cross-sector day on claim construction, the doctrine of equivalents, injunction trends, and Unified Patent Court (UPC) jurisdictional strategy, featuring judges from the UPC and national courts.

Pharma & Biotech Patent Litigation – January 20-21

Covering preliminary injunctions, second medical use, SPCs, Bolar, global biologics/biosimilars litigation, and evolving EU regulatory reforms.

Tech & Innovation Patent Litigation – January 20-21

Focusing on SEP/FRAND enforcement, competition authority activity, AI and IP, patent quality, and strategic venue selection.

New speakers

A few speakers have also confirmed since our last announcement, including the following:

UPC Litigation Forum:

Pharma and Biotech Patent Litigation:

Tech & Innovation Patent Litigation:

We are excited to be joining such a leading event – and, through our collaboration, our readers will receive a 15% registration discount with the code below:

IPFRAY15

You can download the summary pack here and book your ticket here.